Prevention and circumvention of refractoriness to platelet transfusions: interface between preparative and therapeutic apheresis.
Beris
P
P
Blood Transfusion Centre, Geneva University Cantonal Hospital, Switzerland.
Dornier
C
C
D000741:Anemia, Aplastic / Q000628:therapy; D001792:Blood Platelets / Q000276:immunology / Q000528:radiation effects; D001803:Blood Transfusion; D006680:HLA Antigens / Q000276:immunology; D006648:Histocompatibility; D006801:Humans; D007114:Immunization; D007165:Immunosuppression Therapy; D007518:Isoantibodies / Q000096:biosynthesis; D007958:Leukocyte Count; D008213:Lymphocyte Activation / Q000528:radiation effects; D008297:Male; D008875:Middle Aged; D010951:Plasma Exchange; D010976:Platelet Count; D017713:Platelet Transfusion; D010983:Plateletpheresis / Q000295:instrumentation / Q000379:methods; D014184:Transplantation, Homologous / Q000276:immunology; D014466:Ultraviolet Rays
D006680:HLA Antigens; D007518:Isoantibodies